T
Thomas S. Harrison
Researcher at St George's, University of London
Publications - 197
Citations - 14214
Thomas S. Harrison is an academic researcher from St George's, University of London. The author has contributed to research in topics: Meningitis & Cryptococcosis. The author has an hindex of 54, co-authored 170 publications receiving 11308 citations. Previous affiliations of Thomas S. Harrison include University of Cape Town & St George’s University Hospitals NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
John R. Perfect,William E. Dismukes,Françoise Dromer,David L. Goldman,John R. Graybill,Richard J. Hamill,Thomas S. Harrison,Robert A. Larsen,Olivier Lortholary,Olivier Lortholary,Minh Hong Nguyen,Peter G. Pappas,William G. Powderly,Nina Singh,Jack D. Sobel,Tania C. Sorrell +15 more
TL;DR: Emphasis has been placed on potential complications in management of cryptococcal infection, including increased intracranial pressure, immune reconstitution inflammatory syndrome (IRIS), drug resistance, and cryptococcomas.
Journal ArticleDOI
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly,Sharon C.-A. Chen,Carol A. Kauffman,William J. Steinbach,John W. Baddley,Paul E. Verweij,Cornelius J. Clancy,John R. Wingard,Shawn R. Lockhart,Andreas H. Groll,Tania C. Sorrell,Matteo Bassetti,Hamdi Akan,Barbara D. Alexander,David R. Andes,Elie Azoulay,Ralf Bialek,Robert W. Bradsher,Stéphane Bretagne,Thierry Calandra,Angela M. Caliendo,Elio Castagnola,Mario Cruciani,Manuel Cuenca-Estrella,Catherine F. Decker,Sujal R. Desai,Brian T. Fisher,Thomas S. Harrison,Claus Peter Heussel,Henrik Jeldtoft Jensen,Christopher C. Kibbler,Dimitrios P. Kontoyiannis,Bart Jan Kullberg,Katrien Lagrou,Frédéric Lamoth,Thomas Lehrnbecher,J. Loeffler,Olivier Lortholary,Johan Maertens,O. Marchetti,Kieren A. Marr,Henry Masur,Jacques F. Meis,C. Orla Morrisey,Marcio Nucci,Luis Ostrosky-Zeichner,Livio Pagano,Thomas F. Patterson,John R. Perfect,Zdenek Racil,Emmanuel Roilides,Marcus Ruhnke,Cornelia Schaefer Prokop,Shmuel Shoham,Monica A. Slavin,David A. Stevens,George Richard Thompson,Jose A. Vazquez,Claudio Viscoli,Thomas J. Walsh,Adilia Warris,L. Joseph Wheat,P. Lewis White,Theoklis E. Zaoutis,Peter G. Pappas +64 more
TL;DR: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Journal ArticleDOI
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Annemarie E. Brouwer,Adul Rajanuwong,Wirongrong Chierakul,George E. Griffin,Robert A. Larsen,Nicholas J. White,Nicholas J. White,Thomas S. Harrison +7 more
TL;DR: Quantification of CSF cultures provides a powerful new means to accurately assess the fungicidal activity of new treatment regimens for cryptococcal meningitis.
Journal ArticleDOI
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani,Thomas S. Harrison,Andrew J. Nunn,Patrick P. J. Phillips,Gavin J. Churchyard,Salome Charalambous,Mark Hatherill,Hennie Geldenhuys,Helen McIlleron,Simbarashe P. Zvada,Stanley Mungofa,Nasir A. Shah,Simukai Zizhou,Lloyd Magweta,James Shepherd,Sambayawo Nyirenda,Janneke H. van Dijk,Heather Clouting,David Coleman,Anna L.E. Bateson,Timothy D. McHugh,Philip D. Butcher,Denny A. Mitchison +22 more
TL;DR: The 6-month regimen that included weekly administration of high-dose rifapentine and moxifloxacin was as effective as the control regimen and the 4- month regimen was not noninferior to thecontrol regimen.
Journal ArticleDOI
The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.
Kyung J. Kwon-Chung,John E. Bennett,Brian L. Wickes,Wieland Meyer,Christina A. Cuomo,Kurt R. Wollenburg,Tihana Bicanic,Elizabeth Castañeda,Yun C. Chang,Jianghan Chen,Massimo Cogliati,Françoise Dromer,David Ellis,Scott G. Filler,Matthew C. Fisher,Thomas S. Harrison,Steven M. Holland,Shigeru Kohno,James W. Kronstad,Márcia dos Santos Lazéra,Stuart M. Levitz,Michail S. Lionakis,Robin C. May,Popchai Ngamskulrongroj,Peter G. Pappas,John R. Perfect,Volker Rickerts,Tania C. Sorrell,Thomas J. Walsh,Peter R. Williamson,Jianping Xu,Adrian M. Zelazny,Arturo Casadevall +32 more
TL;DR: In the absence of biological differences between clades and no consensus about how DNA sequence alone can delineate a species, it is recommended to use “Cryptococcus neoformans species complex” and “C. gattii speciescomplex” as a practical intermediate step, rather than creating more species.